| scholarly article | Q13442814 |
| P2093 | author name string | Michael A Drebot | |
| Susan J Wong | |||
| Harvey Artsob | |||
| Deepali Kumar | |||
| Atul Humar | |||
| Peter Buck | |||
| Gillian Lim | |||
| P2860 | cites work | Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey | Q24570061 |
| B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. | Q27473103 | ||
| Immunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus Vaccination | Q27480960 | ||
| West Nile virus surveillance and diagnostics: A Canadian perspective | Q27481984 | ||
| First Isolation of West Nile virus from a patient with encephalitis in the United States | Q27489546 | ||
| The outbreak of West Nile virus infection in the New York City area in 1999 | Q29618175 | ||
| West Nile encephalitis epidemic in southeastern Romania | Q29620822 | ||
| West Nile virus: a primer for the clinician | Q29620970 | ||
| Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay | Q30827379 | ||
| Transmission of West Nile virus from an organ donor to four transplant recipients | Q34201110 | ||
| Community-acquired West Nile virus infection in solid-organ transplant recipients | Q35668808 | ||
| Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice | Q40344535 | ||
| West Nile virus: pathogenesis and therapeutic options | Q40536563 | ||
| Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 | Q40550030 | ||
| Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors | Q40901140 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | West Nile virus | Q158856 |
| seroprevalence | Q3511357 | ||
| P304 | page(s) | 1883-1888 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | A seroprevalence study of west nile virus infection in solid organ transplant recipients | |
| P478 | volume | 4 |
| Q40255394 | Arenavirus and West Nile virus in solid organ transplantation. |
| Q33988636 | Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study |
| Q97545604 | Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study |
| Q37611824 | Clinical manifestations and outcomes of West Nile virus infection |
| Q40286544 | Current practices and evaluation of screening solid organ donors for West Nile virus |
| Q36322125 | Development of effective therapies against West Nile virus infection |
| Q38245354 | Donor-derived infection--the challenge for transplant safety. |
| Q38058285 | Emerging viral diseases in kidney transplant recipients |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q27490208 | Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters |
| Q40155194 | Fatal West Nile Virus Encephalitis in a Heart Transplant Recipient |
| Q40242280 | Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010. |
| Q36182414 | Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection |
| Q35466057 | Genetic variants and susceptibility to neurological complications following West Nile virus infection |
| Q33866024 | Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients |
| Q35123912 | Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection |
| Q36148125 | Infectious disease transmission during organ and tissue transplantation |
| Q38545145 | Long-term sequelae of West Nile virus-related illness: a systematic review |
| Q35900167 | Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome |
| Q27489893 | Progress on the development of therapeutics against West Nile virus |
| Q30241036 | Screening of living organ donors for endemic infections: Understanding the challenges and benefits of enhanced screening |
| Q41329151 | Strategies for safe living among lung transplant recipients: a single-center survey |
| Q27485255 | Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation |
| Q37969834 | Vector-borne infections in solid organ transplant recipients |
| Q40228190 | West Nile Virus Infection in the Immunocompromised Patient |
| Q45407334 | West Nile Virus encephalopathy following pancreatic islet transplantation |
| Q40444552 | West Nile encephalitis, status epilepticus and West Nile pneumonia in a renal transplant patient |
| Q37828641 | West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature |
| Q28260103 | West Nile virus meningoencephalitis |
| Q27473254 | West Nile virus. Update for family physicians |
| Q36396283 | West Nile virus: a challenge for transplant programs |
| Q26827766 | West Nile virus: review of the literature |
Search more.